| Code | 42660 | ||||||||||
| MA number | EU/1/03/270/003 | ||||||||||
| Product Form: | emp tdm 2 (3,9 mg/24 hod) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 53 - PARASYMPATHOLYTICA, GANGLIOPLEGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Transdermal use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 15.06.2004 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 21.06.2023 |
